[1] WALSH DP, RAFTERY RM, CHEN G, et al. Rapid healing of a critical‐sized bone defect using a collagen‐hydroxyapatite scaffold to facilitate low dose, combinatorial growth factor delivery. J Tissue Eng Regen M. 2019;13(10):1843-1853.
[2] GARCIA-GARETA E, COATHUP MJ, BLUNN GW, et al. Osteoinduction of bone grafting materials for bone repair and regeneration. Bone. 2015;81(7):112-121.
[3] GE R, XUN C, YANG J, et al. In vivo therapeutic effect of wollastonite and hydroxyapatite on bone defect. Biomed Mater. 2019;14(6):065-073.
[4] MARGONAR R, DOS SPL, QUEIROZ TP, et al. Rehabilitation of Atrophic Maxilla Using the Combination of Autogenous and Allogeneic Bone Grafts Followed by Protocol-Type Prosthesis. J Craniofac Surg. 2010; 21(6):1894-1896.
[5] DU XY, WEI DX, HUANG L, et al. 3D printing of mesoporous bioactive glass/silk fibroin composite scaffolds for bone tissue engineering. Mater Sci Eng C. 2019;103(18):109731.
[6] ROSETI L, PARISI V, PETRETTA M, et al. Scaffolds for Bone Tissue Engineering: State of the art and new perspectives. Mater Sci Eng C. 2017;78(18):1246-1262.
[7] ZHANG YH, MA JL, ZHANG WF. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms. J Ethnopharmacol. 2021;27(7):114249.
[8] WANG YG, WU H, CHEN P, et al. Fertility and early embryonic development toxicity assessment of naringin in Sprague-Dawley rats. Regul Toxicol Pharmacol. 2021;12(3):104938.
[9] RIVOIRA MA, RODRIGUEZ V, TALAMONI G, et al. New Perspectives in the Pharmacological Potential of Naringin in Medicine. Curr Med Chem. 2021;28(10):1987-2007.
[10] KRISTIN E YU, KAREME DA, MONTANA TM, et al. Re-appraising the potential of naringin for natural, novel orthopedic biotherapies. Ther Adv Musculoskelet Dis. 2020;12(1):1-21.
[11] LO KW, ASHE KM, KAN HM, et al. The role of small molecules in musculoskeletal regeneration. Regen Med. 2012;7(4):535-549.
[12] YAN Y, ZHOU H, WU C, et al. Ultrasound-assisted aqueous two-phase extraction of synephrine, naringin, and neohesperidin from Citrus aurantium L. fruitlets. Prep Biochem Biotechnol. 2021;51(8):780-791.
[13] 徐高丽,柳毅,吴立立,等.柚皮苷协同骨形态发生蛋白-2促进小鼠成骨细胞MC3T3-E1增殖和分化的研究[J].华西口腔医学杂志, 2017,35(3):275-280.
[14] 李顺祥,勉龙,张志光.骨碎补的研究进展[J].中国中医药信息杂志,2002,9(11):75-78.
[15] WEI M, YANG Z, LI P, et al. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med. 2007;35(4): 663-667.
[16] ZHANG P, DAI KR, YAN SG, et al. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol. 2009;607(1-3):1-5.
[17] ZHOU XX, ZHANG P, ZHANG C, et al. Promotion of Bone Formation by Naringin in a Titanium Particle-Induced Diabetic Murine Calvarial Osteolysis Model. J Orthop Res. 2010;4(28):452-456.
[18] FAN JF, LI J, QIAN F, et al. Naringin promotes differentiation of bone marrow stem cells into osteoblasts by upregulating the expression levels of microRNA -20a and downregulating the expression levels of PPAR γ. Mol Med Rep. 2015;12(3):4759-4765.
[19] ENSRUD KE, CRANDALL CJ. Osteoporosis. Ann Intern Med. 2017;167(3): ITC17-ITC32.
[20] WU GJ, CHEN JT, CHERNG YG, et al. Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts. J Agric Food Chem. 2020;68(39):10639-10650.
[21] GUO DY, WANG JZ, WANG XQ, et al. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu). J Ethnopharmacol. 2011;138(2):451-457.
[22] TOSHIHISA KOMORI. Animal models for osteoporosis. Eur J Pharmacol. 2015;75(9):287-294.
[23] NOIRRIT-ESCLASSAN E, VALERA M, Tremollieres F, et al. Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications. Int J Mol Sci. 2021;22(4):15-68.
[24] PANG WY, WANG XL, SAU-KENG MOK, et al. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells .Br J Pharmacol. 2010;159(8): 1693-1703.
[25] WU GJ, CHEN KY, YANG JD, et al. Naringin Improves Osteoblast Mineralization and Bone Healing and Strength through Regulating Estrogen Receptor Alpha-Dependent Alkaline Phosphatase Gene Expression. J Agric Food Chem. 2021;69(44):13020-13033.
[26] LV JW, SUN XL, MA JX, et al. Involvement of periostin-sclerostin-Wnt_β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem Biophys Res Commun. 2015; 4(468):587-593.
[27] MA XL, LV JW, SUN XL, et al. Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone. Sci Rep. 2016;6(1):245-262.
[28]. FUKUDA T, TAKEDA S, XU R, et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature. 2013;497(7450):490-493.
[29] ZHANG ZD, REN H, SHEN GY, et al. Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review. Biomed Pharmacother. 2016;84(5):438-446.
[30] SAAG KG, WAGMAN RB, GEUSENS P, et al. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. Lancet Diabetes Endocrinol. 2018;6(6):445-454.
[31] GE XT, ZHOU G. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K/Akt/mTOR signaling pathway.Am J Transl Res. 2021;13(6):6330-6341.
[32] WANG HC, LI CB, LI GM, et al. Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells. Iran J Basic Med Sci. 2017;20(4):408-414.
[33] WANG W, MAO J,CHEN Y, et al. Naringin promotes osteogenesis and ameliorates osteoporosis development by targeting JAK2/STAT3 signalling. Clin Exp Pharmacol Physiol. 2022;49(1):113-121.
[34] LIU MM, LI Y, YANG ST. Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2017;11(1):276-284.
[35] 林春淑, 舒晓春, 肖菲娜, 等. 柚皮苷对高糖作用下MC3T3-E1细胞活力和Akt通路相关因子表达的影响[J]. 中华细胞与肝细胞杂志(电子版). 2020,10(6):321-327.
[36] MATTSON AM, BEGUN DL, MOLSTAD DHH, et al. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice. J Biol Chem. 2019;294(31): 11772-11784.
[37] HIDEKI K, ASEEL M, FUMITOSHI O, et al. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int J Mol Sci. 2020;21(14):51-69.
[38] ESTABELLE SMA, YANG XH, CHEN HH, et al. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation. FEBS Lett. 2011;585(17):2755-2762.
[39] YANG C, LIU W, ZHANG XL, et al. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway. J Orthop Surg Res. 2020;15(1):600.
[40] LI FB, SUN XL, MA JX, et al. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway. Biochemical and Biophysical Research Communications. 2014;452(3):629-635.
[41] RHONDA DP. Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone. J Endocrinol. 2017;235(3):R77-R100.
[42] SONG N, ZHAO ZH, MA XL, et al. Naringin promotes fracture healing through stimulation of angiogenesis by regulating. Chem Biol Interact. 2016;261(1):11-17.
[43] SHANGGUAN WJ, ZHANG YH, LI ZC, et al. Naringin inhibits vascular endothelial cell apoptosis via endoplasmic reticulum stress- and mitochondrial-mediated pathways and promotes intraosseous angiogenesis in ovariectomized rats. Int J Mol Med. 2017;40(6):1741-1749.
[44] ZHAO ZH, MA XL, MA JX, et al. Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway. Chem Biol Interact. 2018;286(1):45-51.
[45] ZHANG P, DAI KR, YAN SG, et al. Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol. 2009;607(1-3):1-5.
[46] PANG WY, WANG XL, SAU-KENG MOK, et al. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br J Pharmacol. 2010;159(8):1693-1703.
[47] AJA A, DAISY MR, JONATHAN NIP, et al. Osteoinductive small molecules: growth factor alternatives for bone tissue engineering. Curr Pharm Des. 2013;19(19):3420-3428.
[48] GULEID A, EDGAR W, KOMAL R, et al.Engineered Bone Tissue with Naturally-Derived Small Molecules. Curr Pharm Des. 2017;23(24):3585-3594.
[49] JI Y, WANG L, WATTS DC, et al. Controlled-release naringin nanoscaffold for osteoporotic bone healing. Dent Mater. 2014;30(11):1263-1273.
[50] JAME C, ADHITHI LK, CHRISTIAN B, et al. Characterization of a prevascularized biomimetic tissue engineered scaffold for bone regeneration. J Biomed Mater Res B Appl Biomater. 2020;108(4):1655-1668.
[51] XUE Y, HUTHAYFA NSA, ZHANG QY, et al. Electrosprayed naringin-loaded microsphere/SAIB hybrid depots enhance bone formation in a mouse calvarial defect model. Drug Deliv. 2019;26(1):137-146.
[52] YU X, SHEN GY, SHANG Q, et al. A Naringin-loaded gelatin-microsphere/nano-hydroxyapatite/silk fibroin composite scaffold promoted healing of critical-size vertebral defects in ovariectomised rat. Int J Biol Macromol. 2021;193(Pt A):510-518.
[53] ZHAO ZH, MA XL, ZHAO B, et al. Naringin-inlaid silk fibroin/hydroxyapatite scaffold enhances human umbilical cord-derived mesenchymal stem cell-based bone regeneration. Cell Prolif. 2021; 54(7):130-143.
[54] GUO ZJ, WU S, LI H, et al. In vitro evaluation of electrospun PLGA/PLLA/PDLLA blend fibers loaded with naringin for guided bone regeneration. Dent Mater J. 2018;37(2):317-324.
[55] YU MF, YOU DQ, ZHANG JJ, et al. Controlled Release of Naringin in Metal-Organic Framework-Loaded Mineralized Collagen Coating to Simultaneously Enhance Osseointegration and Antibacterial Activity. ACS Appl Mater Interfaces. 2017;9(23):19698-19705.
|